New oral antiviral drug to be used for treatment of COVID-19
By Zhang Zhihao |
chinadaily.com.cn |
Updated: 2023-03-23 19:18
Share
Share - WeChat
The National Medical Products Administration has recently granted conditional market approval for an oral antiviral drug RAY1216 in a bid to treat COVID-19.
The drug can be used to treat adults with mild and moderate symptoms of COVID-19, but it must be taken under medical supervision, the administration said.
RAY1216 is a drug developed by Guangdong Zhongsheng Pharmaceutical.
- China reaffirms commitment to fusion energy as two IAEA events open
- Meng Fanli elected governor of China's Guangdong
- Xizang's autumn harvest nearly complete despite rainfall
- Autumn brings migratory birds to grasslands in Baotou
- Theme events carried out across China to mark upcoming World Food Day
- 8 killed, 4 injured in suspected drunk driving accident in East China
